Financial News
Latest News about SNY
Recent news which mentions SNY
Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report
Today 9:12 EST
From Benzinga
Magenta Is Ready to Paint Your Portfolio Green
February 27, 2021
From Motley Fool
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
February 23, 2021
From Benzinga
FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer
February 23, 2021
From Benzinga
From Benzinga
3 Green Flags for Novavax Investors, and 1 Red Flag
February 20, 2021
From Motley Fool
Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg
February 16, 2021
From Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
From Benzinga
Sanofi Offers Cash Buyout For Kiadis
February 12, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
February 10, 2021
From Benzinga
Should You Buy Lexicon Pharmaceuticals Stock?
February 06, 2021
From Motley Fool
What's Behind Regeneron's Stellar Q4 Update
February 05, 2021
From Motley Fool
Regeneron's Q4 Double-Digit Top and Bottom-Line Growth Propelled By Higher Sales From Eylea And Dupixent
February 05, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
Sanofi Swings To Forth Quarter Profit Despite Lower Sales; Expands Cost-Savings Push By €500M
February 05, 2021
From Benzinga
European stocks head for best week since November as investors wait for U.S. jobs data
February 05, 2021
From MarketWatch
Earnings Scheduled For February 5, 2021
February 05, 2021
From Benzinga
Pfizer Is Ready, Even For COVID-19 Variants
February 03, 2021
From Benzinga
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
February 03, 2021
From MarketWatch
2 Growth Stocks for In-the-Know Investors
February 03, 2021
From Motley Fool
Is It Too Late to Buy Pfizer Stock?
February 03, 2021
From Motley Fool
What's the Upside for Novavax Stock?
February 02, 2021
From Motley Fool
A Preview Of The Busy Earnings Week Ahead
February 01, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
